THIS PROJECT CONCERNS THE DEVELOPMENT AND THE IN VITRO AND IN VIVO MODELS IN PRE-CLINICAL MODELS OF AN INNOVATIVE THERAPEUTIC PRODUCT BASED ON THE COMBINATION OF THREE ELEMENTS (EXTRACELLULAR MATRIX, ENDOTHELIAL CELLS AND GROWTH DRIVERS), USING THE AUTOMATIC NANT 001 BIOREACTOR IN ORDER TO ALLOW STANDARDISATION OF THE PROCESS, AVOIDANCE OF TIME AND COST OF THE PROCESS OF AUTOLOGOUS ENDOTHELIAL CELLS (ISOLATED BY A PATIENT BIOPSY IN THE SAME PATIENT WHERE VERRAN